This preview shows page 1. Sign up to view the full content.
Unformatted text preview: mputational models)
by a wide range of potential users, including
researchers, commercial enterprises, healthcare providers, patients and the public.
Researchers themselves need maximum
access to the data as soon as possible (see
‘Data release’, below). Use of the information
for the development of therapeutic and
other products necessarily entails consideration of the complex issues of intellectual
property (for example, patenting and licensing) and commercialization. The intellectual
property practices, laws and regulations that
affect genomics must adhere to the principle
of maximizing public benefit, but must also
be consistent with more general and longerestablished intellectual property principles.
Further, because genome research is global,
international treaties, laws, regulations,
practices, belief systems and cultures also
come into play.
Without commercialization, most diagnostic and therapeutic advances will not
reach the clinical setting, where they can
benefit patients. Thus, we need to d...
View Full Document
This document was uploaded on 04/02/2014.
- Fall '14
- The Tempest